Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages
Kerstin A. Effenberger, Veronica K. Urabe, Beth E. Prichard, et al.
RNA (2016) Vol. 22, Iss. 3, pp. 350-359
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee, Omar Abdel‐Wahab
Nature Medicine (2016) Vol. 22, Iss. 9, pp. 976-986
Open Access | Times Cited: 503
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee, Heidi Dvinge, Eun Hee Kim, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 672-678
Open Access | Times Cited: 335
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 197
Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
Kristen E. Mengwasser, Richard O. Adeyemi, Yumei Leng, et al.
Molecular Cell (2019) Vol. 73, Iss. 5, pp. 885-899.e6
Open Access | Times Cited: 169
Modulating splicing with small molecular inhibitors of the spliceosome
Kerstin A. Effenberger, Veronica K. Urabe, Melissa S. Jurica
Wiley Interdisciplinary Reviews - RNA (2016) Vol. 8, Iss. 2
Open Access | Times Cited: 158
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds
Constantin Cretu, Anant A. Agrawal, Andrew S. Cook, et al.
Molecular Cell (2018) Vol. 70, Iss. 2, pp. 265-273.e8
Open Access | Times Cited: 151
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
Jennifer D. Hintzsche, Nicholas T. Gorden, Carol M. Amato, et al.
Melanoma Research (2017) Vol. 27, Iss. 3, pp. 189-199
Open Access | Times Cited: 139
The biological function and clinical significance of SF3B1 mutations in cancer
Zhixia Zhou, Qiyong Gong, Yin Wang, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Efficient RNA polymerase II pause release requires U2 snRNP function
Livia Caizzi, Sara Monteiro-Martins, Björn Schwalb, et al.
Molecular Cell (2021) Vol. 81, Iss. 9, pp. 1920-1934.e9
Open Access | Times Cited: 68
Pre-mRNA splicing-associated diseases and therapies
Sierra L. Love, Joseph D. Emerson, Kazunori Koide, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 525-538
Open Access | Times Cited: 26
SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast
Tucker J. Carrocci, Douglas Zoerner, Joshua C. Paulson, et al.
Nucleic Acids Research (2016), pp. gkw1349-gkw1349
Open Access | Times Cited: 83
Roles of Fe–S proteins: from cofactor synthesis to iron homeostasis to protein synthesis
Debkumar Pain, Andrew Dancis
Current Opinion in Genetics & Development (2016) Vol. 38, pp. 45-51
Open Access | Times Cited: 68
SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression
Norihiko Kawamura, Keisuke Nimura, Kotaro Saga, et al.
Cancer Research (2019) Vol. 79, Iss. 20, pp. 5204-5217
Open Access | Times Cited: 62
Splicing and cancer: Challenges and opportunities
Patrícia P. Coltri, Maria Gabriela Pereira dos Santos, Guilherme Henrique Gatti da Silva
Wiley Interdisciplinary Reviews - RNA (2019) Vol. 10, Iss. 3
Closed Access | Times Cited: 61
Structural and functional modularity of the U2 snRNP in pre-mRNA splicing
Clarisse van der Feltz, Aaron A. Hoskins
Critical Reviews in Biochemistry and Molecular Biology (2019) Vol. 54, Iss. 5, pp. 443-465
Open Access | Times Cited: 56
Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy
Xuesen Dong, Ruiqi Chen
Oncogene (2019) Vol. 39, Iss. 11, pp. 2231-2242
Closed Access | Times Cited: 55
Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors
Constantin Cretu, Patricia Gee, Xiang Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Splicing modulators: on the way from nature to clinic
Tilman Schneider‐Poetsch, Jagat K Chhipi-Shrestha, Minoru Yoshida
The Journal of Antibiotics (2021) Vol. 74, Iss. 10, pp. 603-616
Open Access | Times Cited: 43
Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
Luisa Vigevani, André Gohr, Thomas R. Webb, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 54
RBM22 regulates RNA polymerase II 5′ pausing, elongation rate, and termination by coordinating 7SK-P-TEFb complex and SPT5
Xian Du, Wenying Qin, Chunyu Yang, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)
Felicia Fei‐Lei Chung, Perry Faith Tze Ming Tan, Vijay J. Raja, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 48
Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells
Qianjing Zhang, Cuixia Di, Junfang Yan, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1273-1280
Open Access | Times Cited: 41
The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data
Marina Wright Muelas, Farah Mughal, Steve O’Hagan, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 40
A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex
Rakesh Chatrikhi, Callen F. Feeney, Mary J. Pulvino, et al.
Cell chemical biology (2021) Vol. 28, Iss. 8, pp. 1145-1157.e6
Open Access | Times Cited: 31
Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities
Maxime Blijlevens, Jing Li, Victor W. van Beusechem
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5110-5110
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top